Timothy C. Dec - Oct 13, 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Senior Vice-President & CFO
Signature
/s/ Timothy C. Dec
Stock symbol
SUPN
Transactions as of
Oct 13, 2023
Transactions value $
-$51,425
Form type
4
Date filed
10/13/2023, 05:00 PM
Previous filing
Oct 6, 2023
Next filing
Feb 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $0 +4K +133.33% $0.00 7K Oct 13, 2023 Direct F1
transaction SUPN Common Stock Tax liability -$51.4K -1.91K -27.3% $26.91 5.09K Oct 13, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Options Exercise $0 -4K -100% $0.00* 0 Oct 13, 2023 Common Stock 4K $0.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 23, 2023.
F2 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting.
F3 On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.